Search

Ping Liu

from Chicago, IL
Get Report
Also known as:
Ping Huan Li
Related to:
Jie Mei Li, 58Fung M Liu
Connected to:
Adela Liu, 73Alec X Liu, 39Alpha T Liu, 46Amon Y Liu, 58Andrea Y Liu, 46Anqi Liu, 39Arden K Liu, 64Ba S Liu, 62Bailu Liu, 35Ban Liu, 48

Ping Liu Phones & Addresses

  • Chicago, IL
  • Watertown, MA

Professional Records

Medicine Doctors

Ping Liu Photo 1

Ping Liu

View page
Specialties:
Internal Medicine
Work:
Newton Memorial Medical Center Hospitalist
175 High St FL 3, Newton, NJ 07860
(973) 383-2121 (phone), (973) 579-8807 (fax)
Education:
Medical School
Tongji Med Univ, Wuhan City, Hubei, China
Graduated: 1992
Conditions:
Acute Pancreatitis
Bacterial Pneumonia
Cardiac Arrhythmia
Cholelethiasis or Cholecystitis
Chronic Bronchitis
Languages:
English
Description:
Dr. Liu graduated from the Tongji Med Univ, Wuhan City, Hubei, China in 1992. She works in Newton, NJ and specializes in Internal Medicine. Dr. Liu is affiliated with Overlook Medical Center.
Ping Liu Photo 2

Ping Liu

View page
Specialties:
Internal Medicine

Lawyers & Attorneys

Ping Liu Photo 3

Ping Liu - Lawyer

View page
Address:
Jsm Beijing Representative Office.
(106) 599-9333 (Office)
Licenses:
New York - Currently registered 2005
Education:
Harvard
Ping Liu Photo 4

Ping Liu, Glenview IL - Lawyer

View page
Address:
Illinois Tool Works, Inc.,
3600 W Lake Ave, Glenview, IL 60026
(847) 657-6186 (Office)
Licenses:
New York - Currently registered 2001
Education:
Northwestern University School of Law
Ping Liu Photo 5

Ping Liu, Glenview IL - Lawyer

View page
Address:
Illinois Tool Works Inc.
3600 W Lakeview Dr, Glenview, IL 60626
(630) 506-0398 (Office)
Licenses:
Illinois - Active And Authorized To Practice Law 2004

Resumes

Resumes

Ping Liu Photo 6

Ping Liu

View page
Work:
Ping Liu

2014 to 2000
Principal Statistician
3M Pharmaceuticals, Inc

May 2005 to Feb 2012
Statistician/lead statistician on several
US and Europe

Aug 2000 to Apr 2005
Lead statistician in Actinic Keratosis project
University of Minnesota

Sep 1998 to Jun 2000
Consultant
Education:
The University of Texas
2007 to 2012
Ph.D in Biostatistics
University of Minnesota
1998 to 2000
M.S in Biostatistics
Fudan University
1992 to 1997
B.S in Genetics & Genetic Engineering
Fudan University
Ping Liu Photo 7

Ping Liu Woodridge, IL

View page
Work:
Illinois Tool Works Inc
Chicago, IL
2011 to 2013
International Tax Supervisor
Navistar, Inc
Chicago, IL
2008 to 2011
International Tax Supervisor
KPMG LLP
Minneapolis, MN
2007 to 2008
Tax Associate, International Corporate Services
Education:
UNIVERSITY OF MINNESOTA LAW SCHOOL
Minneapolis, MN
2001 to 2004
J.D.
NORTHWESTERN UNIVERSITY SCHOOL OF LAW
Chicago, IL
1999 to 2000
LL.M.
PEKING UNIVERSITY LAW SCHOOL
1991 to 1994
Master of Laws

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ping P. Liu
Principal
Glen International Trading Co
Whol Nondurable Goods
1679 Patriot Blvd, Glenview, IL 60026
Ping Liu
Manager
Cuspress, LLC
Ping Liu
President
Eva Enterprise Inc
Business Services
914 Arboretum Way, Burlington, MA 01803
Ping Liu
Manager
Lory Associates LLC
32 Whites Ave, Watertown, MA 02472

Publications

Us Patents

N-Heteroaryl Indazole Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof

View page
US Patent:
20210395236, Dec 23, 2021
Filed:
Oct 25, 2019
Appl. No.:
17/286870
Inventors:
- Rahway NJ, US
William P. KAPLAN - Boston MA, US
Michael J. ARDOLINO - Arlington MA, US
Joanna L. CHEN - Braintree MA, US
Peter H. FULLER - Ashland MA, US
Hakan GUNAYDIN - Somerville MA, US
Derun LI - Roxbury MA, US
Ping LIU - Westfield NJ, US
Kaitlyn Marie LOGAN - Boston MA, US
Joey METHOT - Westwood MA, US
Gregori J. MORRIELLO - Randolph NJ, US
Santhosh F. NEELAMKAVIL - Edison NJ, US
Luis TORRES - Norwood MA, US
Xin YAN - Newton MA, US
Hua ZHOU - Acton MA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 405/14
C07D 403/04
C07D 413/04
C07D 417/04
C07D 413/14
C07D 417/14
C07D 409/14
C07D 401/14
Abstract:
The present invention is directed to substituted certain N-heteroaryl indazole derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein R, R, R, X, Y, and Z are as defined herein, which are potent inhibitors of LRRK2 kinase and may be useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease and other diseases and disorders described herein. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of diseases, such as Parkinson's disease, in which LRRK-2 kinase is involved.

Materials And Methods For Assessing Progression Of Prostate Cancer

View page
US Patent:
20200199687, Jun 25, 2020
Filed:
Feb 20, 2020
Appl. No.:
16/796026
Inventors:
- Des Plaines IL, US
Ekaterina Pestova - Glenview IL, US
Jing Du - Evanston IL, US
Ping Liu - Wilmette IL, US
Tracey Colpitts - Round Lake IL, US
International Classification:
C12Q 1/6886
Abstract:
Methods of distinguishing and identifying a patient with aggressive/indolent, prostatic adenocarcinoma comprising contacting a sample from the patient with a set of detectably labeled probes under hybridization conditions and determining the presence of chromosomal abnormalities in the sample; sets of probes for use in such methods; and kits comprising a set of probes and instructions for distinguishing or identifying a patient as having aggressive/indolent, prostatic adenocarcinoma.

Materials And Methods For Assessing Progression Of Prostate Cancer

View page
US Patent:
20180291466, Oct 11, 2018
Filed:
Jun 11, 2018
Appl. No.:
16/005228
Inventors:
- Des Plaines IL, US
Ekaterina Pestova - Glenview IL, US
Jing Du - Evanston IL, US
Ping Liu - Wilmette IL, US
Tracey Colpitts - Round Lake IL, US
International Classification:
C12Q 1/6886
Abstract:
Methods of distinguishing and identifying a patient with aggressive/indolent, prostatic adenocarcinoma comprising contacting a sample from the patient with a set of detectably labeled probes under hybridization conditions and determining the presence of chromosomal abnormalities in the sample; sets of probes for use in such methods; and kits comprising a set of probes and instructions for distinguishing or identifying a patient as having aggressive/indolent, prostatic adenocarcinoma.

Materials And Methods For Assessing Progression Of Prostate Cancer

View page
US Patent:
20160002735, Jan 7, 2016
Filed:
Jun 30, 2015
Appl. No.:
14/788195
Inventors:
- Des Plaines IL, US
Ekaterina Pestova - Glenview IL, US
Jing Du - Evanston IL, US
Ping Liu - Wilmette IL, US
Tracey Colpitts - Round Lake IL, US
International Classification:
C12Q 1/68
Abstract:
Methods of distinguishing and identifying a patient with aggressive/indolent, prostatic adenocarcinoma comprising contacting a sample from the patient with a set of detectably labeled probes under hybridization conditions and determining the presence of chromosomal abnormalities in the sample; sets of probes for use in such methods; and kits comprising a set of probes and instructions for distinguishing or identifying a patient as having aggressive/indolent, prostatic adenocarcinoma.
Control profile
Ping Liu from Chicago, IL Get Report